Sponsor
This activity is jointly sponsored by the Medical Learning Institute, Inc. (a nonprofit medical accreditation company), and Center of Excellence Media, LLC. Target Audience This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.

Learning Objectives
Upon completion of this activity, the participant will be able to:

• Explain the impact of key clinical data presented at ASH 2010 on payers and providers in the treatment and management of non-Hodgkin lymphoma (NHL)
• Identify patient/disease-associated factors, as well as economic factors that may affect the choice of a therapeutic agent and be able to formulate a management strategy using a risk-adapted approach to the treatment of NHL
• Construct informed treatment decisions for the purpose of improving the long-term outlook for patients with NHL across the lifecycle of the disease
• Identify and discuss the future of NHL treatment and the potential clinical, business, and regulatory changes that could affect the benefit design cost-value

Commercial Support Acknowledgment
This activity is supported by an educational grant from Genentech.

Instructions for Credit
There is no fee for this activity. After reading this CE activity in its entirety, participants must complete the posttest and evaluation. The posttest and evaluation can be completed online at www.mlicme.org/p11008.html. Upon completion of the evaluation and scoring 70% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 70% or better on the posttest, you will be asked to take it again.

Please retain a copy of the certificate for your records. For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc., at 609-333-1693 or cgusack@mlicme.org.

Pharmacists Designation
Medical Learning Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal activity number for this activity is 0468-9999-11-003-H01-P.

Faculty Disclosures
Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker’s bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.

John Fox, MD, and James T. Kenney, RPh, MBA, have nothing to disclose.

Caroline Helwick has stock ownership at Micronet.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and Center of Excellence Media, LLC, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE activity for any amount during the past 12 months.

Disclaimer
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Estimated time to complete activity: 1 hour
Initial Release Date: February 28, 2011
Expiration Date: February 28, 2012

PDF: 

Download PDF